Login
$LCTX
$0.80 +$0.00 (0.0%) After hours

$LCTX 8-K/A SEC Filings

Filed On Filing
30 Sep 2022 8-K/A: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

25 Apr 2019 8-K/A: Financial Statements and Exhibits

The following sets forth the unaudited pro forma condensed combined financial statements (the “Pro Forma Financial Statements”) of BioTime after giving effect to the Merger with Asterias (the “Merger”), which was completed on March 8, 20...

14 Aug 2017 8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders

Michael D. West, Ph.D., Aditya Mohanty, and Judith Segall certify that:

16 Jul 2010 8-K/A: Completion of Acquisition or Disposition of Assets

Financial Statements for Years Ended March 31, 2009 and 2010

24 Oct 2007 8-K/A: Departure/Election of Directors or Officers; Compensation

The following sentence amends the corresponding information included in BioTime’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 12, 2007.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support